Cargando…

Systemic Toxicity of Intraperitoneal Vancomycin

Intraperitoneal vancomycin is used for empiric treatment of peritoneal dialysis peritonitis. It is dosed intermittently and a high systemic concentration is often achieved. Despite this, there are very few reports of systemic toxicity from intraperitoneal vancomycin. We report the course of a patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Teerath, Teo, Iris, McCormick, Brendan B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093231/
https://www.ncbi.nlm.nih.gov/pubmed/27840751
http://dx.doi.org/10.1155/2016/3968690
_version_ 1782464875299078144
author Kumar, Teerath
Teo, Iris
McCormick, Brendan B.
author_facet Kumar, Teerath
Teo, Iris
McCormick, Brendan B.
author_sort Kumar, Teerath
collection PubMed
description Intraperitoneal vancomycin is used for empiric treatment of peritoneal dialysis peritonitis. It is dosed intermittently and a high systemic concentration is often achieved. Despite this, there are very few reports of systemic toxicity from intraperitoneal vancomycin. We report the course of a patient who developed a drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after three weeks of intraperitoneal vancomycin. We review the literature and conclude that this is the first ever reported case of DRESS syndrome from intraperitoneal vancomycin.
format Online
Article
Text
id pubmed-5093231
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-50932312016-11-13 Systemic Toxicity of Intraperitoneal Vancomycin Kumar, Teerath Teo, Iris McCormick, Brendan B. Case Rep Nephrol Case Report Intraperitoneal vancomycin is used for empiric treatment of peritoneal dialysis peritonitis. It is dosed intermittently and a high systemic concentration is often achieved. Despite this, there are very few reports of systemic toxicity from intraperitoneal vancomycin. We report the course of a patient who developed a drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome after three weeks of intraperitoneal vancomycin. We review the literature and conclude that this is the first ever reported case of DRESS syndrome from intraperitoneal vancomycin. Hindawi Publishing Corporation 2016 2016-10-20 /pmc/articles/PMC5093231/ /pubmed/27840751 http://dx.doi.org/10.1155/2016/3968690 Text en Copyright © 2016 Teerath Kumar et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kumar, Teerath
Teo, Iris
McCormick, Brendan B.
Systemic Toxicity of Intraperitoneal Vancomycin
title Systemic Toxicity of Intraperitoneal Vancomycin
title_full Systemic Toxicity of Intraperitoneal Vancomycin
title_fullStr Systemic Toxicity of Intraperitoneal Vancomycin
title_full_unstemmed Systemic Toxicity of Intraperitoneal Vancomycin
title_short Systemic Toxicity of Intraperitoneal Vancomycin
title_sort systemic toxicity of intraperitoneal vancomycin
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5093231/
https://www.ncbi.nlm.nih.gov/pubmed/27840751
http://dx.doi.org/10.1155/2016/3968690
work_keys_str_mv AT kumarteerath systemictoxicityofintraperitonealvancomycin
AT teoiris systemictoxicityofintraperitonealvancomycin
AT mccormickbrendanb systemictoxicityofintraperitonealvancomycin